As of 2025-12-04, the EV/EBITDA ratio of Blueprint Medicines Corp (BPMC) is -54.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BPMC's latest enterprise value is 8,637.68 mil USD. BPMC's TTM EBITDA according to its financial statements is -157.63 mil USD. Dividing these 2 quantities gives us the above BPMC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 12.6x | 11.4x |
| Forward P/E multiples | 10.6x - 21.1x | 12.4x |
| Fair Price | (30.04) - (34.91) | (33.11) |
| Upside | -123.2% - -127.0% | -125.6% |
| Date | EV/EBITDA |